Cetuximab |
Cetuximab Products |
| New therapeutic options backed for colorectal cancer.(Bevacizumab, Cetuximab, Folfox): An article from: Internal Medicine News Jeff Evans International Medical News Group International Medical News Group |
Sale Price: $5.95
|
| Guidelines advocate new colorectal cancer agents: bevacizumab, cetuximab, folfox.(News): An article from: Family Practice News Jeff Evans International Medical News Group International Medical News Group |
Sale Price: $5.95
|
| Head and neck cancers stalled with cetuximab.(Clinical Rounds): An article from: Internal Medicine News Erik L. Goldman International Medical News Group International Medical News Group |
Sale Price: $5.95
|
| FDA approves cetuximab for colorectal cancer: target therapy for metastatic disease.(Rx): An article from: Family Practice News Elizabeth Mechcatie International Medical News Group International Medical News Group |
Sale Price: $5.95
|
| Cetuximab boosted survival in head and neck cancer patients.(Clinical Rounds): An article from: Family Practice News International Medical News Group International Medical News Group |
Sale Price: $5.95
|

Not Signed In - 

